Latest Breaking News On - Sterghios moschos - Page 4 : comparemela.com
As Britain Reopens, Scientists Warn of Fertile Ground for Coronavirus Variants - New Delhi Times
newdelhitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newdelhitimes.com Daily Mail and Mail on Sunday newspapers.
Britain s Gamble: Freedom Day Announced Amid Rising COVID Cases - New Delhi Times - India s Only International Newspaper
newdelhitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newdelhitimes.com Daily Mail and Mail on Sunday newspapers.
PulmoBioMed Wins National Life Science Competition
Newly launched Northumbria University spinout PulmoBioMed has been handpicked as the winners of Onyx Health s ThinkBig competition
Healthcare marketing communications agency, Onyx Health, have chosen innovative MedTech spinout PulmoBioMed as the winner of their £5,000 #ThinkBig competition, designed to help life science companies bounce back from the COVID-19 crisis.
Having been chosen as the lucky winner of the competition, PulmoBioMed will receive £5,000 of Onyx Health’s full range of specialist healthcare communications support for free, helping them achieve commercial success and access key target markets. #ThinkBig is aimed at innovative start-ups and SMEs in the health and life science sectors, who are at the cutting edge of the industry and can bring something distinctive to the market.
Pfizer Inc and BioNTech said new clinical trial data signalled that their COVID-19 vaccine could protect against the new coronavirus variant first discovered in South Africa.
The shot was 100 percent effective in preventing illness among trial participants in South Africa, where the new B1351 coronavirus variant is dominant, the companies said. The South Africa trial was relatively small, with 800 participants.
Pfizer said the rate was derived from a relatively small number of nine infections observed, all in the placebo group.
Separately, the companies said their vaccine is approximately 91 percent effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months.
Bulgaria has stopped using the AstraZeneca COVID-19 vaccine, joining a small number of European countries that have halted its use after reports that some recipients developed serious blood clots.
Fears over the safety of the vaccine rose on Sunday when Austria announced it had stopped using a batch of AstraZeneca shots while investigating one person’s death from coagulation disorders, and another’s illness from a pulmonary embolism.
Concerns mounted on Thursday when Denmark, Norway and Iceland said they were also suspending the use of the vaccine, jointly produced with the University of Oxford.
Bulgaria’s Prime Minister Boyko Borissov said in a statement on Friday that the use of the vaccine would be paused “until all doubts are dispelled and as long as the experts do not give guarantees that it does not pose a risk to the people”.
vimarsana © 2020. All Rights Reserved.